Table 3 Association between maspin expression and clinicopathological factors in triple-negative breast cancer
From: Maspin expression is frequent and correlates with basal markers in triple-negative breast cancer
| Â | Maspin expression | Â | |
|---|---|---|---|
| Â | Positive (85.9%) 116 cases | Negative (14.1%) 19 cases | P -value |
Age (years) | Â | Â | Â |
   ≤50 | 50 | 1 | 0.0015 |
   >50 | 66 | 18 |  |
Tumor size (mm) | Â | Â | Â |
   ≤20 | 41 | 3 | 0.091 |
   >20 | 75 | 16 |  |
Lymph node metastases | Â | Â | Â |
   0 | 69 | 13 | 0.226 |
   1-3 | 27 | 1 |  |
   3< | 20 | 4 |  |
Histological grade | Â | Â | Â |
   I | 4 | 1 | 0.0013 |
   II | 19 | 10 |  |
   III | 93 | 8 |  |
EGFR | Â | Â | Â |
   Positive | 57 | 9 | 0.886 |
   Negative | 59 | 10 |  |
CK5/6 | Â | Â | Â |
   Positive | 77 | 3 | <0.0001 |
   Negative | 39 | 16 |  |
CK14 | Â | Â | Â |
   Positive | 45 | 1 | 0.0034 |
   Negative | 71 | 18 |  |
CD10 | Â | Â | Â |
   Positive | 19 | 5 | 0.293 |
   Negative | 97 | 14 |  |
p63 | Â | Â | Â |
   Positive | 15 | 2 | 0.769 |
   Negative | 101 | 17 |  |